Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Venue 22
About the venue
Rooms
Call for abstracts
Programme 22
Tracks 22
Speakers 22
Side events 22
Subscribe
days
hours
minutes
seconds
Criminal justice/prisons
Sessions
Wednesday, 23 November
13:20
Drug problems, perspectives and patterns of use
13:20
to
14:50
Networking zone 4 (N4)
Short communication session
16:50
Treatment options for drug users in prisons in Central Asia and Germany
16:50
to
18:20
Networking zone 1 (N1)
Structured session
Thursday, 24 November
15:00
Drug deaths: A social, structural and systems analysis
15:00
to
16:30
Knowledge market 1 (K1)
Structured session
16:50
Prison and drugs: exploring social determinants and pathways to drug problem and incarceration
16:50
to
18:20
Central square 1 (C1)
Structured session
Friday, 25 November
10:50
Substance use and prison
10:50
to
12:20
Central square 1 (C1)
Oral presentation session
13:20
Barriers in the implementation of harm reduction interventions in European prisons. From evidence to practice
13:20
to
14:50
Main stage
Structured session
Presentations
Wednesday, 23 November
13:20
Short communication
Substance use and re-imprisonment: A longitudinal study of the Norwegian Offender Mental Health and Addiction (NorMA) cohort
13:20
to
14:50
Networking zone 4 (N4)
Nicoline Lokdam
Short communication
The age of onset and quitting of drug use is rising
13:20
to
14:50
Networking zone 4 (N4)
Andreja Drev
Short communication
The impact of music on the addictive trajectory: perspective from young adults who experience homelessness.
13:20
to
14:50
Networking zone 4 (N4)
Elise Cournoyer Lemaire
Short communication
Anabolic-androgenic steroid dependence and muscle dysmorphia: an exploratory network analysis
13:20
to
14:50
Networking zone 4 (N4)
Morgan Scarth
Short communication
The use of psychoactive substances among residents of long-term care facilities for the elderly : perspectives of residents, providers and administrators on the current situation, challenges and improvement of practices.
13:20
to
14:50
Networking zone 4 (N4)
Emile Bernier
Short communication
Sharing is caring: Expressions and dynamics within the social supply of illegal drugs
13:20
to
14:50
Networking zone 4 (N4)
Olga S. Cruz
16:50
Oral presentation
3. Health and social welfare in prisons in the Republic of Kazakhstan – women with HIV and the role of the social worker
16:50
to
18:20
Networking zone 1 (N1)
Dalida Mukasheva
Oral presentation
1. The role of social work in agency processes - empirical study using the example of people who use illicit substances with a history of imprisonment
16:50
to
18:20
Networking zone 1 (N1)
Daniela Jamin
Oral presentation
2. Social work with drug users in a probation system of Kyrgyzstan
16:50
to
18:20
Networking zone 1 (N1)
Estebes uulu Tynchtyk
Thursday, 24 November
15:00
Oral presentation
5. Drug Policy and The Rise and Decline of Racial Stratification of Prescribing and Overdose Mortality
15:00
to
16:30
Knowledge market 1 (K1)
Brian Kelly
Oral presentation
1. Drug-related deaths among young people: a social, structural and systems autopsy
15:00
to
16:30
Knowledge market 1 (K1)
Aileen O'Gorman
Oral presentation
2. Drug-related deaths in prisons in England and Wales, 2015-2020: an examination of key trends and issues for policy and practice
15:00
to
16:30
Knowledge market 1 (K1)
Karen Duke
Oral presentation
3. The role of Primary Care in the prevention of drug-related deaths: Patient and family member perspectives
15:00
to
16:30
Knowledge market 1 (K1)
Katie Colliver
Discussion
What can a social, structural and systems analysis tell us about drug-related deaths and what are the implications for policy and addiction science?
15:00
to
16:30
Knowledge market 1 (K1)
Anne Whittaker
Oral presentation
4. The role of Primary Care in the prevention of drug-related deaths: service provider perspectives
15:00
to
16:30
Knowledge market 1 (K1)
Betsy Thom
16:50
Discussion
Common pathways to problematic drug use and incarceration and lessons learnt for policy and practice
16:50
to
18:20
Central square 1 (C1)
Liesbeth Vandam
Oral presentation
1. Use pathways in prison. A French literature review
16:50
to
18:20
Central square 1 (C1)
Caroline Protais
Oral presentation
2. Characteristics associated with drug use during the current detention – results from prison surveys in 4 EU countriessurveys in 4 EU countries
16:50
to
18:20
Central square 1 (C1)
Els Plettinckx
Oral presentation
5. Social determinants, health service contacts and incarceration among all those dying from an accidental overdose 2010-2018 in Norway
16:50
to
18:20
Central square 1 (C1)
Ellen J. Amundsen
Oral presentation
3. Reimprisonment rates among men who inject drugs in Victoria, Australia
16:50
to
18:20
Central square 1 (C1)
Ashleigh C. Stewart
Oral presentation
4. Adverse childhood experiences, substance use, and involvement with correctional services
16:50
to
18:20
Central square 1 (C1)
Richard Pates
Oral presentation
6. Wasted': the complex trajectories from incarceration to recovery. A personal experience
16:50
to
18:20
Central square 1 (C1)
Mark Johnson Ferguson
Friday, 25 November
10:50
Oral presentation
Factors associated with mortality in The Norwegian Offender Mental Health and Addiction (NorMA)- cohort
10:50
to
12:20
Central square 1 (C1)
Torill Tverborgvik
Oral presentation
All cause and cause specific mortality among individuals imprisoned for driving under the influence of alcohol and drugs in Norway (2000-2016)
10:50
to
12:20
Central square 1 (C1)
Ragnhild Jamt
Oral presentation
The Impact of Co-Occurring Mental Health Problems on Referral to and Initiation of Treatment Among Youth Under Probation Supervision
10:50
to
12:20
Central square 1 (C1)
Steven Belenko
Oral presentation
(Ex-)inmates' substance use: a needs assessment based on semi-structured interviews
10:50
to
12:20
Central square 1 (C1)
Nicky Dirkx
Oral presentation
Prevalence of heroin drug use before and during imprisonment in Europe: results from a comprehensive literature review and analysis of prevalence data in six European countries
10:50
to
12:20
Central square 1 (C1)
Sara Mazzilli
13:20
Oral presentation
4. Impact, role, and prevalence of medication assisted treatment (MAT) for opioid users in European prisons
13:20
to
14:50
Main stage
Heino Stöver
Oral presentation
1. Provision of harm reduction interventions in European prisons: short overview of available services
13:20
to
14:50
Main stage
Linda Montanari
Oral presentation
2. Hepatitis C and HIV associated risk factors among people in prison in Latvia, Lithuania, Portugal, Spain: informing interventions to prevent communicable diseases in prison setting
13:20
to
14:50
Main stage
Laura Isajeva
Oral presentation
3. The international guidance on harm reduction interventions in prisons
13:20
to
14:50
Main stage
Ehab Salah
Oral presentation
5. Harm reduction interventions and viral hepatitis elimination in prison: models of care and barriers for implementation
13:20
to
14:50
Main stage
Lara Tavoschi
Discussion
Prison health in Europe
13:20
to
14:50
Main stage
Fadi Meroueh,
Filipa Alves da Costa